Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 9,375 RIGL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 9,375 | n/a |
| Jun 3, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Tax Withholding | 850 | $25.4K |
| Feb 19, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 18,894 | n/a |
| Feb 12, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Tax Withholding | 3,758 | $130.1K |
| Sep 17, 2025 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 7,394 | n/a |
| Mar 20, 2025 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 9,375 | n/a |
| Jan 31, 2025 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 19,717 | n/a |
| Mar 29, 2024 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 187,500 | n/a |
| Mar 17, 2023 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 150,000 | n/a |
| Feb 28, 2023 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 4,127 | n/a |